Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Growth Analysis And Indications – Includes Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Research
Avail a limited period discount of 33% on our uniquely designed Opportunities and Strategies market research reports. Contact us today and make winning strategies!
Major players in the lateral flow immunoassay (LFIA) based rapid test market include Abbott Laboratories, F. Hoffmann-La Roche, Quidel Corporation, Becton, Dickinson and Company, Danaher Corporation.
TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.
The lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $11.05 billion in 2021 to $6.83 billion in 2026 at a rate of -9.2%. The global LFIA based rapid test market size is then expected to grow at a CAGR of 6.9% from 2026 and reach $9.54 billion in 2031.
North America was the largest region in the global lateral flow immunoassay (LFIA) based rapid test market.
The LFIA based rapid test market consists of sales of LFIA based rapid test equipment used to run lateral flow immunoassays LFIA based rapid test and related services by companies that develop LFIA based rapid test equipment. These are testing devices used to assess the existence of a target, such as pathogens or biomarkers, in samples of urine, blood or saliva obtained from the human body.
The growing demand for home-based lateral flow assay devices in expected to support the LFIA based rapid test market in the forecast period.
Technological advancements are a key driver in the LFIA based rapid test market. Companies are gradually increasing innovation in lateral flow assay-based Point of Care (PoC) devices for applications such as pregnancy testing, ovulation monitoring, screening for infectious diseases and drugs of abuse, and the measurement of protein markers in the blood to aid rapid clinical diagnostics of life-threatening events (such as heart attacks, strokes, and deep-vein thrombosis).
TBRC’s Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report Segments:
By Technique: Competitive Assay, Sandwich Assay, Multiplex Detection Assay
By End-User: Hospital and Clinic, Diagnostic Laboratory, Home Care, Other
By Application: Infectious Disease, Pregnancy and Fertility, Toxicology, Other
By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022 –Opportunities And Strategies – Global Forecast To 2031 is one of a series of new reports from The Business Research Company that provides an overview of the lateral flow immunoassay (LFIA) based rapid test market globally and regionally, analyzes and forecasts market size, share, lateral flow immunoassay (LFIA) based rapid test market players, lateral flow immunoassay (LFIA) based rapid test market segments, leading competitor revenues, profiles and market shares.
Here Is A List Of Similar Reports From The Business Research Company:
Interested To Know More About The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: